Schedule 13D ownership disclosure
INTERCEPT PHARMACEUTICALS IN
Security class unavailable · CUSIP: 45845P108
Event date: 2015-03-26
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 4.9500%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000947871-15-000266
- Form type
- SC 13D
- Filer
- INTERCEPT PHARMACEUTICALS, INC.
- CIK
- CIK 1270073
- Filed
- Mar 30, 2015
- Reporting period
- Mar 26, 2015
- Description
- Schedule 13D beneficial ownership